Sellas Life Sciences
Price & Volume
Stats
See more52W Range | $0.65-$1.84 |
Market Cap | $110.8M |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -82.5% |
Gross Profit (12 Mos) | $900,000 |
Diluted EPS | -$0.67 |
News
See moreYahoo Finance • 10 days ago
SELLAS Life Sciences Group Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Yahoo Finance • 15 days ago
SELLAS Life Sciences Announces Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of GPS in Acute Myeloid Leukemia
About
CEO | Dr. Angelos M. Stergiou M.D., ScD h.c. |
CFO | Mr. John Thomas Burns CPA |
Address | Times Square Tower, New York, NY, United States, 10036 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 16 |
